Related references
Note: Only part of the references are listed.A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys
Shanaka Stanislaus et al.
ENDOCRINOLOGY (2017)
Understanding the Physiology of FGF21
Ffolliott Martin Fisher et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Soluble Prokaryotic Expression and Purification of Human Interferon Alpha-2b Using a Maltose-Binding Protein Tag
Thu Trang Thi Vu et al.
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2016)
Expression and purification of FGF21 in Pichia pastoris and its effect on fibroblast-cell migration
Yonghuan Song et al.
MOLECULAR MEDICINE REPORTS (2016)
Prokaryotic Soluble Overexpression and Purification of Human VEGF165 by Fusion to a Maltose Binding Protein Tag
Minh Tan Nguyen et al.
PLOS ONE (2016)
Construction of Escherichia coli Mutant with Decreased Endotoxic Activity by Modifying Lipid A Structure
Qiong Liu et al.
MARINE DRUGS (2015)
The Fibroblast Growth Factor signaling pathway
David M. Ornitz et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
Soluble overexpression and purification of bioactive human CCL2 in E-coli by maltose-binding protein
Thu Trang Thi Vu et al.
MOLECULAR BIOLOGY REPORTS (2015)
Prokaryotic Soluble Overexpression and Purification of Bioactive Human Growth Hormone by Fusion to Thioredoxin, Maltose Binding Protein, and Protein Disulfide Isomerase
Minh Tan Nguyen et al.
PLOS ONE (2014)
Soluble Prokaryotic Overexpression and Purification of Bioactive Human Granulocyte Colony-Stimulating Factor by Maltose Binding Protein and Protein Disulfide Isomerase
Bich Hang Do et al.
PLOS ONE (2014)
Residual Endotoxin Contaminations in Recombinant Proteins Are Sufficient to Activate Human CD1c+ Dendritic Cells
Harald Schwarz et al.
PLOS ONE (2014)
Soluble prokaryotic expression and purification of crotamine using an N-terminal maltose-binding protein tag
Thu Trang Thi Vu et al.
TOXICON (2014)
FGF21-based pharmacotherapy - potential utility for metabolic disorders
Ruth E. Gimeno et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Expression and Purification of Biologically Active Human FGF2 Containing the b′a′ Domains of Human PDI in Escherichia coli
Jung-A Song et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2013)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
Alexei Kharitonenkov et al.
PLOS ONE (2013)
Large-scale expression, purification, and glucose uptake activity of recombinant human FGF21 in Escherichia coli
Minjing Zhang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2012)
The Ability to Enhance the Solubility of Its Fusion Partners Is an Intrinsic Property of Maltose-Binding Protein but Their Folding Is Either Spontaneous or Chaperone-Mediated
Sreejith Raran-Kurussi et al.
PLOS ONE (2012)
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
Fredirick L. Mashili et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli
Huiyan Wang et al.
BMC BIOTECHNOLOGY (2010)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
FGF21 N- and C-termini play different roles in receptor interaction and activation
Junming Yie et al.
FEBS LETTERS (2009)
Different Roles of N- and C-Termini in the Functional Activity of FGF21
Radmila Micanovic et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
Alexei Kharitonenkov et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c
Masashi Suzuki et al.
MOLECULAR ENDOCRINOLOGY (2008)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
βKlotho is required for metabolic activity of fibroblast growth factor 21
Yasushi Ogawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
Regina Goetz et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Receptor tyrosine kinases: mechanisms of activation and signaling
Stevan R. Hubbard et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Alexei Kharitonenkov et al.
ENDOCRINOLOGY (2007)
Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways
Wolf Wente et al.
DIABETES (2006)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli -: art. no. 1
HP Sorensen et al.
MICROBIAL CELL FACTORIES (2005)
The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity
NJ Harmer et al.
BIOCHEMISTRY (2004)
Tobacco etch virus protease:: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency
RB Kapust et al.
PROTEIN ENGINEERING (2001)
Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies
H Bach et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
T Nishimura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)
Share Paper
